PAM
CORT icon

Panagora Asset Management’s Corcept Therapeutics CORT Stock Holding History

Panagora Asset Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,925
Closed -$516K – 1494
2022
Q1 		$516K Hold
22,925
– – ﹤0.01% 1198
2021
Q4 		$454K Sell
22,925
-12,041
-34% -$244K ﹤0.01% 1254
2021
Q3 		$688K Hold
34,966
– – ﹤0.01% 1156
2021
Q2 		$769K Sell
34,966
-260,503
-88% -$5.8M ﹤0.01% 1134
2021
Q1 		$7.03M Sell
295,469
-68,519
-19% -$1.83M 0.04% 383
2020
Q4 		$9.52M Sell
363,988
-56,644
-13% -$1.19M 0.06% 294
2020
Q3 		$7.32M Buy
420,632
+259,433
+161% +$4.13M 0.05% 306
2020
Q2 		$2.71M Buy
161,199
+118,514
+278% +$1.67M 0.02% 566
2020
Q1 		$508K Hold
42,685
– – ﹤0.01% 1109
2019
Q4 		$516K Hold
42,685
– – ﹤0.01% 1291
2019
Q3 		$603K Buy
+42,685
New +$525K ﹤0.01% 1220
2017
Q1 		– Sell
-47,032
Closed -$341K – 2387
2016
Q4 		$341K Hold
47,032
– – ﹤0.01% 1576
2016
Q3 		$305K Buy
47,032
+36,645
+353% +$213K ﹤0.01% 1606
2016
Q2 		$57K Hold
10,387
– – ﹤0.01% 2033
2016
Q1 		$49K Hold
10,387
– – ﹤0.01% 2019
2015
Q4 		$52K Buy
+10,387
New +$46.9K ﹤0.01% 1967
2015
Q2 		– Sell
-9,813
Closed -$55K – 2427
2015
Q1 		$55K Hold
9,813
– – ﹤0.01% 2069
2014
Q4 		$29K Hold
9,813
– – ﹤0.01% 2117
2014
Q3 		$26K Hold
9,813
– – ﹤0.01% 2123
2014
Q2 		$27K Sell
9,813
-570
-5% -$1.68K ﹤0.01% 2199
2014
Q1 		$45K Buy
+10,383
New +$36.3K ﹤0.01% 2112

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Panagora Asset Management's CORT Position: Q2 2022 in Review

Panagora Asset Management sold out of Corcept Therapeutics (CORT) in Q2 2022, closing a stake of 22,925 shares — an estimated $516K sold.

Panagora Asset Management first reported a position in CORT in Q1 2014 and held it in 21 quarters. The position peaked at $9.52M in Q4 2020. 225 funds tracked by Wall St. Rank hold CORT as of Q2 2022.

  • Panagora Asset Management reported no remaining Corcept Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Panagora Asset Management sold 22,925 Corcept Therapeutics shares in Q2 2022, an estimated $516K.
  • Panagora Asset Management first reported a position in Corcept Therapeutics in Q1 2014 and held it in 21 quarters.
  • Panagora Asset Management's Corcept Therapeutics position peaked at $9.52M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.